Assay to determine efficacy of treatment for m. tuberculosis infection
CA 2433236 C · Owner: Lalvani, Ajit · Inventors: Lalvani, Ajit
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Method of determining the efficacy of treatment for mycobacterial infection in an individual comprising determining in samples from the individual whether the level of T cells specific for a mycobacterial antigen has decreased after the treatment, thereby determining the efficacy of the treatment.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 8, 2002 and granted October 4, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 8, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 8, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.